🇺🇸 FDA
Patent

US 6423696

Inhibition of arylamine N-acetyl transferase

expired A61KA61K31/136A61K31/18

Quick answer

US patent 6423696 (Inhibition of arylamine N-acetyl transferase) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K31/136, A61K31/18, A61K31/4409, A61K31/505